Catheter Precision
VTAK
10 hedge funds and large institutions have $57.2K invested in Catheter Precision in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
1.83% less ownership
Funds ownership: 4.32% → 2.5% (-1.8%)
17% less funds holding
Funds holding: 12 → 10 (-2)
44% less capital invested
Capital invested by funds: $103K → $57.2K (-$45.7K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$15.5K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$8.1K |
| 3 |
VF
Virtu Financial
New York
|
+$6.06K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.28K |
| 5 |
Citigroup
New York
|
+$20 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$33.9K |
| 2 |
Millennium Management
New York
|
-$13.3K |
| 3 |
Jane Street
New York
|
-$11.5K |
| 4 |
HF
HRT Financial
New York
|
-$11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $17K | +$6.06K | +6,389 | +47% |
|
|
2
UBS Group
Zurich,
Switzerland
| $14.5K | +$15.5K | +16,302 | +2,148% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $10.2K | -$33.9K | -35,682 | -75% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $8.03K | +$5.28K | +5,558 | +143% |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| $7.26K | +$8.1K | +8,540 | New |
|
|
AF
6
Allworth Financial
Folsom,
California
| $255 | – | – | – |
|
|
7
Citigroup
New York
| $19 | +$20 | +21 | +2,100% |
|
|
PUI
8
Purpose Unlimited Inc
Toronto,
| $9 | – | – | – |
|
|
HI
9
Harbour Investments
Madison,
Wisconsin
| $7 | – | – | – |
|
|
SS
10
SBI Securities
Tokyo,
Japan
| $4 | – | – | – |
|
|
11
Millennium Management
New York
| – | -$13.3K | -13,137 | Closed |
|
|
12
Jane Street
New York
| – | -$11.5K | -11,379 | Closed |
|
|
HF
13
HRT Financial
New York
| – | -$11K | -11,276 | Closed |
|
VTAK Hedge Fund Activity: Q2 2026 in Review
10 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2026, worth a combined $57.2K — down 44% from $103K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VTAK and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 4 added.
The largest buyer was UBS Group, adding an estimated $15.5K. The largest seller was Geode Capital Management, cutting an estimated $33.9K.
- 10 institutional investors held Catheter Precision (VTAK) as of Q2 2026, down from 12 in Q1 2026.
- Funds reported $57.2K of Catheter Precision stock for Q2 2026, down 44% quarter-over-quarter.
- 1 fund opened new Catheter Precision positions in Q2 2026 and 3 closed out, a net change of -2 holders.
- The largest Catheter Precision buyer in Q2 2026 was UBS Group, an estimated $15.5K added.
- The largest Catheter Precision seller in Q2 2026 was Geode Capital Management, an estimated $33.9K sold.
Based on aggregated 13F filings for Q2 2026.